Get the Stockscreener App
0.5818
0.65%
-0.0038
After Hours:
.58
-0.0018
-0.31%
Pavmed Inc stock is traded at $0.5818, with a volume of 74,198.
It is down -0.65% in the last 24 hours and down -5.38% over the past month.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
See More
Previous Close:
$0.5856
Open:
$0.584
24h Volume:
74,198
Relative Volume:
0.49
Market Cap:
$9.94M
Revenue:
$4.03M
Net Income/Loss:
$24.32M
P/E Ratio:
-0.1353
EPS:
-4.3008
Net Cash Flow:
$-45.76M
1W Performance:
-3.56%
1M Performance:
-5.38%
6M Performance:
-10.22%
1Y Performance:
-44.06%
1-Day Range:
$0.577
$0.5999
1-Week Range:
$0.577
$0.62
52-Week Range:
$0.542
$1.90
Pavmed Inc Stock (PAVM) Company Profile
Name
Pavmed Inc
Sector
Industry
Phone
(212) 949-4319
Address
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
0.5818 | 10.13M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.69B | 4.15B | 623.10M | 6.95 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-05-20 | Initiated | Ascendiant Capital Markets | Buy |
| Jun-28-18 | Initiated | Maxim Group | Buy |
Pavmed Inc Stock (PAVM) Latest News
PAVmed Inc. Stock Analysis and ForecastExplosive capital appreciation - PrintWeekIndia
What analysts say about PAVmed Inc. stockFree Consultation - Autocar Professional
Will PAVmed Inc. stock split in the near futureFree Market Dynamics Reports - jammulinksnews.com
What drives PAVmed Inc. stock pricePhenomenal capital appreciation - PrintWeekIndia
Is PAVmed Inc. a good long term investmentFree Consultation - PrintWeekIndia
Why PAVmed Inc. stock attracts strong analyst attentionFree Real-Time Market Predictions - beatles.ru
Lucid says meeting scheduled to determine Medicare coverage for cancer test - MSN
Lucid says AdCom meeting set to determine cancer test coverage - Seeking Alpha
MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test - StreetInsider
How PAVmed Inc. stock performs during market volatilityFree Low-Risk Investment Plans - Newser
What makes PAVmed Inc. stock price move sharplyLow Volatility High Yield Stocks - Newser
PAVmed's Veris Health Secures $2.5M at $35M Valuation to Advance Revolutionary Cancer Monitor - Stock Titan
PAVmed’s Veris Health Completes $2.5M Offering - TipRanks
PAVmed Holds Annual Stockholders Meeting, Approves Key Proposals - TipRanks
Leading California Hospital Network Launches Revolutionary 3-Minute Cancer Detection Test from Lucid Diagnostics - Stock Titan
Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test - Finansavisen
PAVmed (NASDAQ:PAVM) Given New $19.00 Price Target at Ascendiant Capital Markets - Defense World
PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know - MSN
PAVM: Ascendiant Capital Maintains Buy Rating but Lowers Price Target | PAVM Stock News - GuruFocus
PAVmed subsidiary Veris Health partners with Ohio State University cancer center - Yahoo Finance
Pavmed's Veris Health Signs Long-Term Partnership Deal With Ohio State University Hospital - marketscreener.com
PAVmed Subsidiary, Veris Health, Enters into Strategic Partnersh - GuruFocus
PAVM Subsidiary Veris Health Partners with OSUCCC -- James for Cancer Care Innovations | PAVM Stock News - GuruFocus
PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer CenterJames Cancer Hospital and Solove Research Institute | PAVM Sto - GuruFocus
Pavmed Inc Stock (PAVM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):